Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Berro Rivera

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Cardiorenal Medicine|February 22, 2023
Aortic Stenosis and Aortic Valve Replacement among Patients with Chronic Kidney Disease: A Narrative ReviewFrederick Berro Rivera, Maria Victoria Valenzona Cu, Sharmaine Jesselyn Cua, et al.
American Journal of Preventive Cardiology|March 29, 2024
Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regressionFrederick Berro Rivera, Sung Whoy Cha, Michelle Capahi Varona, et al.
American Journal of Preventive Cardiology|May 23, 2024
Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trialsFrederick Berro Rivera, Linnaeus Louisse A Cruz, John Vincent Magalong, et al.
Heart & Lung : the Journal of Critical Care|May 19, 2024
Sex differences in transcatheter aortic valve replacement outcomes among patients with bicuspid aortic stenosisFrederick Berro Rivera, Sung Whoy Cha, Sonny C Redula, et al.
Diabetes, Obesity & Metabolism|March 20, 2024
Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regressionFrederick Berro Rivera, Grace Nooriza O Lumbang, Danielle Rose Magno Gaid, et al.
JACC. Advances|January 29, 2025
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled TrialsFrederick Berro Rivera, Sung Whoy Cha, Cruz Linnaeus Louisse, et al.
JACC. Advances|November 30, 2025
Valvular Heart Disease Interventional Trials From 2000 to 2024: A Systematic ReviewFrederick Berro Rivera, Chieh-Mei Tsai, Polyn Luz S Pine, et al.
Current Medical Research and Opinion|June 5, 2024
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regressionFrederick Berro Rivera, Sung Whoy Cha, John Vincent Magalong, et al.
American Heart Journal|August 6, 2023
Cardiovascular disease in Filipino American men and women: A 2023 updateFrederick Berro Rivera, Sung Whoy Cha, Marie Francesca Mapua Ansay, et al.
JACC. Advances|November 25, 2024
Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists: A Systematic ReviewFrederick Berro Rivera, Mc John Caro Ybañez, John Vincent Magalong, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cardiorenal Medicine|February 22, 2023
Aortic Stenosis and Aortic Valve Replacement among Patients with Chronic Kidney Disease: A Narrative ReviewFrederick Berro Rivera, Maria Victoria Valenzona Cu, Sharmaine Jesselyn Cua, et al.
American Journal of Preventive Cardiology|March 29, 2024
Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regressionFrederick Berro Rivera, Sung Whoy Cha, Michelle Capahi Varona, et al.
American Journal of Preventive Cardiology|May 23, 2024
Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trialsFrederick Berro Rivera, Linnaeus Louisse A Cruz, John Vincent Magalong, et al.
Heart & Lung : the Journal of Critical Care|May 19, 2024
Sex differences in transcatheter aortic valve replacement outcomes among patients with bicuspid aortic stenosisFrederick Berro Rivera, Sung Whoy Cha, Sonny C Redula, et al.
Diabetes, Obesity & Metabolism|March 20, 2024
Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regressionFrederick Berro Rivera, Grace Nooriza O Lumbang, Danielle Rose Magno Gaid, et al.
JACC. Advances|January 29, 2025
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled TrialsFrederick Berro Rivera, Sung Whoy Cha, Cruz Linnaeus Louisse, et al.
JACC. Advances|November 30, 2025
Valvular Heart Disease Interventional Trials From 2000 to 2024: A Systematic ReviewFrederick Berro Rivera, Chieh-Mei Tsai, Polyn Luz S Pine, et al.
Current Medical Research and Opinion|June 5, 2024
Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regressionFrederick Berro Rivera, Sung Whoy Cha, John Vincent Magalong, et al.
American Heart Journal|August 6, 2023
Cardiovascular disease in Filipino American men and women: A 2023 updateFrederick Berro Rivera, Sung Whoy Cha, Marie Francesca Mapua Ansay, et al.
JACC. Advances|November 25, 2024
Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists: A Systematic ReviewFrederick Berro Rivera, Mc John Caro Ybañez, John Vincent Magalong, et al.
Pageof 4